Antipsychotic Drugs Market - Forecast(2024 - 2030)

Report Code: HCR 83890 Report Format: PDF + Excel

Antipsychotic Drugs Market Report

Overview

The Antipsychotic Drugs market size is $14.96 billion in 2018. The global Antipsychotic Drugs Market has been forecasted to reach $19.74 billion by 2025, growing at a CAGR of 4.0% during the forecast period 2019-2025. The market is currently witnessing a growth owing to the increasing prevalence of psychotic disorders reported globally. Also, the huge investments for research and development to create new drugs are further fueling market growth.

Key Takeaways

The North America region has been estimated to hold the largest revenue share owing to the higher prevalence of psychotic disorders in the region as well as the greater availability of advanced healthcare.

The growing prevalence of psychotic disorders worldwide is said to drive the market growth. Companies are also investing in research for developing better drug formulations for combating these mental disorders.

The drugs used for the treatment of these disorders is known to cause addiction if taken in higher quantities. This is considered as a major challenge to the overall market.

Drug Class - Segment Analysis

The second generation drug class holds the largest share in the drug class segment due to having less side effects and higher therapeutic efficiency. However, the third generation drugs are said to have the fastest growth rate with CAGR of 3.5% during the forecast period, owing to the safety and tolerability compared to other generation of drugs. Commonly administered antipsychotic drugs include perphenazine, thiothixene, chlorpromazine hcl, haloperidol, loxapine succinate and others.

Application Type - Segment Analysis

The application of the drugs in the treatment of schizophrenia is estimated to hold the largest share currently. As per WHO, Schizophrenia affects 20 million people worldwide. However, depression is the most common mental disorder affecting all ages and is said to have the fastest growth rate.

Geography - Segment Analysis

The North America region has been estimated to dominate the Antipsychotic Drugs market share with 46%. This is owing to the increasing prevalence of disorders. As per the U.S. National Institute of Mental Health, the prevalence of schizophrenia and related psychotic disorders range between 0.25% and 0.64% in the U.S. Also, Asia Pacific is likely to have a faster growth rate in the coming years due to growing population, increasing healthcare expenditure and increasing awareness programs regarding the usage of these drugs.

Drivers – Antipsychotic Drugs Market

Increasing Prevalence of Psychotic Disorders

The overall global prevalence of psychotic disorders like schizophrenia and depression is increasing at a quick rate. This factor has the potential to be a major market driver for the antipsychotic drugs market. Growing awareness regarding the complications of these disorders and the appropriate treatment is set to fuel the market growth.

Funding for Research and Development

There is a significant rise in the funding for the research and development of effective newer formulations with lesser side effects. This could also be considered as a major market driver as new funding into the research and development could increase the chance of the discovery of a new product to treat psychotic disorders.

Challenges – Antipsychotic Drugs Market

Risk of Addiction

These drugs, when over prescribed, could cause severe complications and also addiction. People are increasingly becoming aware of these problems and this can prove to be a major market constraint. This is more apparent for the people from the more developed parts of the world like North America. This has forced the governments to have even stronger regulations regarding these drugs further limiting the market growth.

Antipsychotic Drugs Industry Outlook

Partnerships and product launches are the key strategies adopted by the major players in the antipsychotic drugs market. Antipsychotic Drugs top 10 companies are Eli Lilly and Company, AstraZeneca, Pfizer Inc., GlaxoSmithKline PLC, Johnson & Johnson, Allergan, Bristol-Myers Squibb, Actavis Generics, Alkermes, and Otsuka Pharmaceutical Co., Ltd.

Developments:

On May 2019, Vraylar from Allergan got an approval from the FDA for the treatment of depressive episodes of bipolar disorder. The company claims that this product will bring in a sales of $683 million in 2019.

On March 2015, GSK had become a partner in a new global fund that is focused on dementia research. The company had provided an investment of $25 million dollars.

Antipsychotic Drugs Market Research Scope:

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. These provide the key market participants with the necessary business intelligence and help them understand the future of the Antipsychotic Drugs Market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats.

1. Antipsychotic Drugs Market - Overview
        1.1 Definitions and Scope
2. Antipsychotic Drugs Market - Executive summary
        2.1 Market Revenue, Market Size and Key Trends by Company
        2.2 Key Trends by type of Application
        2.3 Key Trends segmented by Geography
3. Antipsychotic Drugs Market
        3.1 Comparative analysis
            3.1.1 Product Benchmarking - Top 10 companies
            3.1.2 Top 5 Financials Analysis
            3.1.3 Market Value split by Top 10 companies
            3.1.4 Patent Analysis - Top 10 companies
            3.1.5 Pricing Analysis
4. Antipsychotic Drugs Market - Startup companies Scenario Premium
        4.1 Top 10 startup company Analysis by
            4.1.1 Investment
            4.1.2 Revenue
            4.1.3 Market Shares
            4.1.4 Market Size and Application Analysis
            4.1.5 Venture Capital and Funding Scenario
5. Antipsychotic Drugs Market - Industry Market Entry Scenario Premium
        5.1 Regulatory Framework Overview
        5.2 New Business and Ease of Doing business index
        5.3 Case studies of successful ventures
        5.4 Customer Analysis - Top 10 companies
6. Antipsychotic Drugs Market Forces
        6.1 Drivers
        6.2 Constraints
        6.3 Challenges
        6.4 Porters five force model
            6.4.1 Bargaining power of suppliers
            6.4.2 Bargaining powers of customers
            6.4.3 Threat of new entrants
            6.4.4 Rivalry among existing players
            6.4.5 Threat of substitutes
7. Antipsychotic Drugs Market -Strategic analysis
        7.1 Value chain analysis
        7.2 Opportunities analysis
        7.3 Product life cycle
        7.4 Suppliers and distributors Market Share
8. Antipsychotic Drugs Market - By Product Type (Market Size -$Million / $Billion)
        8.1 Market Size and Market Share Analysis
        8.2 Application Revenue and Trend Research
        8.3 Product Segment Analysis
9. Antipsychotic Drugs Market - By Drug Class (Market Size -$Million / $Billion)
        9.1 First Generation/Standard/Typical Antipsychotic Drug
        9.2 Haldol Market
        9.3 Navane Market
        9.4 Other Market
        9.5 Second Generation/Atypical Antipsychotic Drug
        9.6 Zyprexa Market
        9.7 Seroquel Market
        9.8 Risperdal Market
        9.9 Invega Market
        9.10 Latuda Market
        9.11 Others Market
        9.12 Third Generation Antipsychotic Drug
10. Antipsychotic Drugs - By Application Type (Market Size -$Million / $Billion)
        10.1 Schizophrenia
        10.2 Bipolar Disorder
        10.3 Depression
        10.4 Dementia
        10.5 Other Psychotic Disorder
11. Antipsychotic Drugs- By Geography (Market Size -$Million / $Billion)
        11.1 Antipsychotic Drugs Market - North America Segment Research
        11.2 North America Market Research (Million / $Billion)
            11.2.1 Segment type Size and Market Size Analysis
            11.2.2 Revenue and Trends
            11.2.3 Application Revenue and Trends by type of Application
            11.2.4 Company Revenue and Product Analysis
            11.2.5 North America Product type and Application Market Size
                  11.2.5.1 U.S
                  11.2.5.2 Canada
                  11.2.5.3 Mexico
                  11.2.5.4 Rest of North America
        11.3 Antipsychotic Drugs- South America Segment Research
        11.4 South America Market Research (Market Size -$Million / $Billion)
            11.4.1 Segment type Size and Market Size Analysis
            11.4.2 Revenue and Trends
            11.4.3 Application Revenue and Trends by type of Application
            11.4.4 Company Revenue and Product Analysis
            11.4.5 South America Product type and Application Market Size
                  11.4.5.1 Brazil
                  11.4.5.2 Venezuela
                  11.4.5.3 Argentina
                  11.4.5.4 Ecuador
                  11.4.5.5 Peru
                  11.4.5.6 Colombia
                  11.4.5.7 Costa Rica
                  11.4.5.8 Rest of South America
        11.5 Antipsychotic Drugs- Europe Segment Research
        11.6 Europe Market Research (Market Size -$Million / $Billion)
            11.6.1 Segment type Size and Market Size Analysis
            11.6.2 Revenue and Trends
            11.6.3 Application Revenue and Trends by type of Application
            11.6.4 Company Revenue and Product Analysis
            11.6.5 Europe Segment Product type and Application Market Size
                  11.6.5.1 U.K
                  11.6.5.2 Germany
                  11.6.5.3 Italy
                  11.6.5.4 France
                  11.6.5.5 Netherlands
                  11.6.5.6 Belgium
                  11.6.5.7 Denmark
                  11.6.5.8 Spain
                  11.6.5.9 Rest of Europe
        11.7 Antipsychotic Drugs - APAC Segment Research
        11.8 APAC Market Research (Market Size -$Million / $Billion)
            11.8.1 Segment type Size and Market Size Analysis
            11.8.2 Revenue and Trends
            11.8.3 Application Revenue and Trends by type of Application
            11.8.4 Company Revenue and Product Analysis
            11.8.5 APAC Segment - Product type and Application Market Size
                  11.8.5.1 China
                  11.8.5.2 Australia
                  11.8.5.3 Japan
                  11.8.5.4 South Korea
                  11.8.5.5 India
                  11.8.5.6 Taiwan
                  11.8.5.7 Malaysia
                  11.8.5.8 Hong kong
                  11.8.5.9 Rest of APAC
        11.9 Antipsychotic Drugs - Middle East Segment and Africa Segment Research
        11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
            11.10.1 Segment type Size and Market Size Analysis
            11.10.2 Revenue and Trend Analysis
            11.10.3 Application Revenue and Trends by type of Application
            11.10.4 Company Revenue and Product Analysis
            11.10.5 Middle East Segment Product type and Application Market Size
                  11.10.5.1 Israel
                  11.10.5.2 Saudi Arabia
                  11.10.5.3 UAE
            11.10.6 Africa Segment Analysis
                  11.10.6.1 South Africa
                  11.10.6.2 Rest of Middle East & Africa
12. Antipsychotic Drugs Market - Entropy
        12.1 New product launches
        12.2 M&A s, collaborations, JVs and partnerships
13. Antipsychotic Drugs Market - Industry / Segment Competition landscape Premium
        13.1 Market Share Analysis
            13.1.1 Market Share by Country- Top companies
            13.1.2 Market Share by Region- Top 10 companies
            13.1.3 Market Share by type of Application - Top 10 companies
            13.1.4 Market Share by type of Product / Product category- Top 10 companies
            13.1.5 Market Share at global level - Top 10 companies
            13.1.6 Best Practises for companies
14. Antipsychotic Drugs Market - Key Company List by Country Premium
15. Antipsychotic Drugs Market Company Analysis
        15.1 Market Share, Company Revenue, Products, M&A, Developments
        15.2 Allergan
        15.3 Astrazeneca
        15.4 Bristol-Myers Squibb Company
        15.5 Eli Lilly Co
        15.6 Geographic Foothold
        15.7 Glaxo Smithkline, Plc
        15.8 Johnson Johnson
        15.9 Pfizer, Inc
        15.10 Company 9
        15.11 Company 10 & More
*Financials would be provided on a best efforts basis for private companies
16. Antipsychotic Drugs Market - Appendix
        16.1 Abbreviations
        16.2 Sources
17. Antipsychotic Drugs Market - Methodology
        17.1 Research Methodology
            17.1.1 Company Expert Interviews
            17.1.2 Industry Databases
            17.1.3 Associations
            17.1.4 Company News
            17.1.5 Company Annual Reports
            17.1.6 Application Trends
            17.1.7 New Products and Product database
            17.1.8 Company Transcripts
            17.1.9 R&D Trends
            17.1.10 Key Opinion Leaders Interviews
            17.1.11 Supply and Demand Trends

LIST OF TABLES

1.Global Antipsychotic Drug Market:Drug Class Estimate Trend Analysis Market 2023-2030 ($M)
1.1 First Generation/Standard/Typical Antipsychotic Drug Market 2023-2030 ($M) - Global Industry Research
1.1.1 First Generation/Standard/Typical Antipsychotic Drug Market Estimate Forecast Market 2023-2030 ($M)
1.2 Haldol Market Market 2023-2030 ($M) - Global Industry Research
1.2.1 Haldol Market Estimate Forecast Market 2023-2030 ($M)
1.3 Navane Market Market 2023-2030 ($M) - Global Industry Research
1.3.1 Navane Market Estimate Forecast Market 2023-2030 ($M)
1.5 Second Generation/Atypical Antipsychotic Drug Market 2023-2030 ($M) - Global Industry Research
1.5.1 Second Generation/Atypical Antipsychotic Drug Market Market Estimate Forecast Market 2023-2030 ($M)
1.6 Zyprexa Market Market 2023-2030 ($M) - Global Industry Research
1.6.1 Zyprexa Market Estimate Forecast Market 2023-2030 ($M)
1.7 Seroquel Market Market 2023-2030 ($M) - Global Industry Research
1.7.1 Seroquel Market Estimate Forecast Market 2023-2030 ($M)
1.8 Risperdal Market Market 2023-2030 ($M) - Global Industry Research
1.8.1 Risperdal Market Estimate Forecast Market 2023-2030 ($M)
1.9 Invega Market Market 2023-2030 ($M) - Global Industry Research
1.9.1 Invega Market Estimate Forecast Market 2023-2030 ($M)
1.10 Latuda Market Market 2023-2030 ($M) - Global Industry Research
1.10.1 Latuda Market Estimate Forecast Market 2023-2030 ($M)
1.12 Third Generation Antipsychotic Drug Market 2023-2030 ($M) - Global Industry Research
1.12.1 Third Generation Antipsychotic Drug Market Market 2023-2030 ($M)
2.Global Antipsychotic Drug Market:Application Estimate Trend Analysis Market 2023-2030 ($M)
2.1 Schizophrenia Market 2023-2030 ($M) - Global Industry Research
2.1.1 Schizophrenia Market Estimate Forecast Market 2023-2030 ($M)
2.2 Bipolar Disorder Market 2023-2030 ($M) - Global Industry Research
2.2.1 Bipolar Disorder Market Estimate Forecast Market 2023-2030 ($M)
2.3 Depression Market 2023-2030 ($M) - Global Industry Research
2.3.1 Depression Market Estimate Forecast Market 2023-2030 ($M)
2.4 Dementia Market 2023-2030 ($M) - Global Industry Research
2.4.1 Dementia Market Estimate Forecast Market 2023-2030 ($M)
3.Global Antipsychotic Drug Market:Drug Class Estimate Trend Analysis Market 2023-2030 (Volume/Units)
3.1 First Generation/Standard/Typical Antipsychotic Drug Market 2023-2030 (Volume/Units) - Global Industry Research
3.1.1 First Generation/Standard/Typical Antipsychotic Drug Market Estimate Forecast Market 2023-2030 (Volume/Units)
3.2 Haldol Market Market 2023-2030 (Volume/Units) - Global Industry Research
3.2.1 Haldol Market Estimate Forecast Market 2023-2030 (Volume/Units)
3.3 Navane Market Market 2023-2030 (Volume/Units) - Global Industry Research
3.3.1 Navane Market Estimate Forecast Market 2023-2030 (Volume/Units)
3.5 Second Generation/Atypical Antipsychotic Drug Market 2023-2030 (Volume/Units) - Global Industry Research
3.5.1 Second Generation/Atypical Antipsychotic Drug Market Market Estimate Forecast Market 2023-2030 (Volume/Units)
3.6 Zyprexa Market Market 2023-2030 (Volume/Units) - Global Industry Research
3.6.1 Zyprexa Market Estimate Forecast Market 2023-2030 (Volume/Units)
3.7 Seroquel Market Market 2023-2030 (Volume/Units) - Global Industry Research
3.7.1 Seroquel Market Estimate Forecast Market 2023-2030 (Volume/Units)
3.8 Risperdal Market Market 2023-2030 (Volume/Units) - Global Industry Research
3.8.1 Risperdal Market Estimate Forecast Market 2023-2030 (Volume/Units)
3.9 Invega Market Market 2023-2030 (Volume/Units) - Global Industry Research
3.9.1 Invega Market Estimate Forecast Market 2023-2030 (Volume/Units)
3.10 Latuda Market Market 2023-2030 (Volume/Units) - Global Industry Research
3.10.1 Latuda Market Estimate Forecast Market 2023-2030 (Volume/Units)
3.12 Third Generation Antipsychotic Drug Market 2023-2030 (Volume/Units) - Global Industry Research
3.12.1 Third Generation Antipsychotic Drug Market Market 2023-2030 (Volume/Units)
4.Global Antipsychotic Drug Market:Application Estimate Trend Analysis Market 2023-2030 (Volume/Units)
4.1 Schizophrenia Market 2023-2030 (Volume/Units) - Global Industry Research
4.1.1 Schizophrenia Market Estimate Forecast Market 2023-2030 (Volume/Units)
4.2 Bipolar Disorder Market 2023-2030 (Volume/Units) - Global Industry Research
4.2.1 Bipolar Disorder Market Estimate Forecast Market 2023-2030 (Volume/Units)
4.3 Depression Market 2023-2030 (Volume/Units) - Global Industry Research
4.3.1 Depression Market Estimate Forecast Market 2023-2030 (Volume/Units)
4.4 Dementia Market 2023-2030 (Volume/Units) - Global Industry Research
4.4.1 Dementia Market Estimate Forecast Market 2023-2030 (Volume/Units)
5.North America Antipsychotic Drug Market:Drug Class Estimate Trend Analysis Market 2023-2030 ($M)
5.1 First Generation/Standard/Typical Antipsychotic Drug Market 2023-2030 ($M) - Regional Industry Research
5.1.1 First Generation/Standard/Typical Antipsychotic Drug Market Estimate Forecast Market 2023-2030 ($M)
5.2 Haldol Market Market 2023-2030 ($M) - Regional Industry Research
5.2.1 Haldol Market Estimate Forecast Market 2023-2030 ($M)
5.3 Navane Market Market 2023-2030 ($M) - Regional Industry Research
5.3.1 Navane Market Estimate Forecast Market 2023-2030 ($M)
5.5 Second Generation/Atypical Antipsychotic Drug Market 2023-2030 ($M) - Regional Industry Research
5.5.1 Second Generation/Atypical Antipsychotic Drug Market Market Estimate Forecast Market 2023-2030 ($M)
5.6 Zyprexa Market Market 2023-2030 ($M) - Regional Industry Research
5.6.1 Zyprexa Market Estimate Forecast Market 2023-2030 ($M)
5.7 Seroquel Market Market 2023-2030 ($M) - Regional Industry Research
5.7.1 Seroquel Market Estimate Forecast Market 2023-2030 ($M)
5.8 Risperdal Market Market 2023-2030 ($M) - Regional Industry Research
5.8.1 Risperdal Market Estimate Forecast Market 2023-2030 ($M)
5.9 Invega Market Market 2023-2030 ($M) - Regional Industry Research
5.9.1 Invega Market Estimate Forecast Market 2023-2030 ($M)
5.10 Latuda Market Market 2023-2030 ($M) - Regional Industry Research
5.10.1 Latuda Market Estimate Forecast Market 2023-2030 ($M)
5.12 Third Generation Antipsychotic Drug Market 2023-2030 ($M) - Regional Industry Research
5.12.1 Third Generation Antipsychotic Drug Market Market 2023-2030 ($M)
6.North America Antipsychotic Drug Market:Application Estimate Trend Analysis Market 2023-2030 ($M)
6.1 Schizophrenia Market 2023-2030 ($M) - Regional Industry Research
6.1.1 Schizophrenia Market Estimate Forecast Market 2023-2030 ($M)
6.2 Bipolar Disorder Market 2023-2030 ($M) - Regional Industry Research
6.2.1 Bipolar Disorder Market Estimate Forecast Market 2023-2030 ($M)
6.3 Depression Market 2023-2030 ($M) - Regional Industry Research
6.3.1 Depression Market Estimate Forecast Market 2023-2030 ($M)
6.4 Dementia Market 2023-2030 ($M) - Regional Industry Research
6.4.1 Dementia Market Estimate Forecast Market 2023-2030 ($M)
7.South America Antipsychotic Drug Market:Drug Class Estimate Trend Analysis Market 2023-2030 ($M)
7.1 First Generation/Standard/Typical Antipsychotic Drug Market 2023-2030 ($M) - Regional Industry Research
7.1.1 First Generation/Standard/Typical Antipsychotic Drug Market Estimate Forecast Market 2023-2030 ($M)
7.2 Haldol Market Market 2023-2030 ($M) - Regional Industry Research
7.2.1 Haldol Market Estimate Forecast Market 2023-2030 ($M)
7.3 Navane Market Market 2023-2030 ($M) - Regional Industry Research
7.3.1 Navane Market Estimate Forecast Market 2023-2030 ($M)
7.5 Second Generation/Atypical Antipsychotic Drug Market 2023-2030 ($M) - Regional Industry Research
7.5.1 Second Generation/Atypical Antipsychotic Drug Market Market Estimate Forecast Market 2023-2030 ($M)
7.6 Zyprexa Market Market 2023-2030 ($M) - Regional Industry Research
7.6.1 Zyprexa Market Estimate Forecast Market 2023-2030 ($M)
7.7 Seroquel Market Market 2023-2030 ($M) - Regional Industry Research
7.7.1 Seroquel Market Estimate Forecast Market 2023-2030 ($M)
7.8 Risperdal Market Market 2023-2030 ($M) - Regional Industry Research
7.8.1 Risperdal Market Estimate Forecast Market 2023-2030 ($M)
7.9 Invega Market Market 2023-2030 ($M) - Regional Industry Research
7.9.1 Invega Market Estimate Forecast Market 2023-2030 ($M)
7.10 Latuda Market Market 2023-2030 ($M) - Regional Industry Research
7.10.1 Latuda Market Estimate Forecast Market 2023-2030 ($M)
7.12 Third Generation Antipsychotic Drug Market 2023-2030 ($M) - Regional Industry Research
7.12.1 Third Generation Antipsychotic Drug Market Market 2023-2030 ($M)
8.South America Antipsychotic Drug Market:Application Estimate Trend Analysis Market 2023-2030 ($M)
8.1 Schizophrenia Market 2023-2030 ($M) - Regional Industry Research
8.1.1 Schizophrenia Market Estimate Forecast Market 2023-2030 ($M)
8.2 Bipolar Disorder Market 2023-2030 ($M) - Regional Industry Research
8.2.1 Bipolar Disorder Market Estimate Forecast Market 2023-2030 ($M)
8.3 Depression Market 2023-2030 ($M) - Regional Industry Research
8.3.1 Depression Market Estimate Forecast Market 2023-2030 ($M)
8.4 Dementia Market 2023-2030 ($M) - Regional Industry Research
8.4.1 Dementia Market Estimate Forecast Market 2023-2030 ($M)
9.Europe Antipsychotic Drug Market:Drug Class Estimate Trend Analysis Market 2023-2030 ($M)
9.1 First Generation/Standard/Typical Antipsychotic Drug Market 2023-2030 ($M) - Regional Industry Research
9.1.1 First Generation/Standard/Typical Antipsychotic Drug Market Estimate Forecast Market 2023-2030 ($M)
9.2 Haldol Market Market 2023-2030 ($M) - Regional Industry Research
9.2.1 Haldol Market Estimate Forecast Market 2023-2030 ($M)
9.3 Navane Market Market 2023-2030 ($M) - Regional Industry Research
9.3.1 Navane Market Estimate Forecast Market 2023-2030 ($M)
9.5 Second Generation/Atypical Antipsychotic Drug Market 2023-2030 ($M) - Regional Industry Research
9.5.1 Second Generation/Atypical Antipsychotic Drug Market Market Estimate Forecast Market 2023-2030 ($M)
9.6 Zyprexa Market Market 2023-2030 ($M) - Regional Industry Research
9.6.1 Zyprexa Market Estimate Forecast Market 2023-2030 ($M)
9.7 Seroquel Market Market 2023-2030 ($M) - Regional Industry Research
9.7.1 Seroquel Market Estimate Forecast Market 2023-2030 ($M)
9.8 Risperdal Market Market 2023-2030 ($M) - Regional Industry Research
9.8.1 Risperdal Market Estimate Forecast Market 2023-2030 ($M)
9.9 Invega Market Market 2023-2030 ($M) - Regional Industry Research
9.9.1 Invega Market Estimate Forecast Market 2023-2030 ($M)
9.10 Latuda Market Market 2023-2030 ($M) - Regional Industry Research
9.10.1 Latuda Market Estimate Forecast Market 2023-2030 ($M)
9.12 Third Generation Antipsychotic Drug Market 2023-2030 ($M) - Regional Industry Research
9.12.1 Third Generation Antipsychotic Drug Market Market 2023-2030 ($M)
10.Europe Antipsychotic Drug Market:Application Estimate Trend Analysis Market 2023-2030 ($M)
10.1 Schizophrenia Market 2023-2030 ($M) - Regional Industry Research
10.1.1 Schizophrenia Market Estimate Forecast Market 2023-2030 ($M)
10.2 Bipolar Disorder Market 2023-2030 ($M) - Regional Industry Research
10.2.1 Bipolar Disorder Market Estimate Forecast Market 2023-2030 ($M)
10.3 Depression Market 2023-2030 ($M) - Regional Industry Research
10.3.1 Depression Market Estimate Forecast Market 2023-2030 ($M)
10.4 Dementia Market 2023-2030 ($M) - Regional Industry Research
10.4.1 Dementia Market Estimate Forecast Market 2023-2030 ($M)
11.APAC Antipsychotic Drug Market:Drug Class Estimate Trend Analysis Market 2023-2030 ($M)
11.1 First Generation/Standard/Typical Antipsychotic Drug Market 2023-2030 ($M) - Regional Industry Research
11.1.1 First Generation/Standard/Typical Antipsychotic Drug Market Estimate Forecast Market 2023-2030 ($M)
11.2 Haldol Market Market 2023-2030 ($M) - Regional Industry Research
11.2.1 Haldol Market Estimate Forecast Market 2023-2030 ($M)
11.3 Navane Market Market 2023-2030 ($M) - Regional Industry Research
11.3.1 Navane Market Estimate Forecast Market 2023-2030 ($M)
11.5 Second Generation/Atypical Antipsychotic Drug Market 2023-2030 ($M) - Regional Industry Research
11.5.1 Second Generation/Atypical Antipsychotic Drug Market Market Estimate Forecast Market 2023-2030 ($M)
11.6 Zyprexa Market Market 2023-2030 ($M) - Regional Industry Research
11.6.1 Zyprexa Market Estimate Forecast Market 2023-2030 ($M)
11.7 Seroquel Market Market 2023-2030 ($M) - Regional Industry Research
11.7.1 Seroquel Market Estimate Forecast Market 2023-2030 ($M)
11.8 Risperdal Market Market 2023-2030 ($M) - Regional Industry Research
11.8.1 Risperdal Market Estimate Forecast Market 2023-2030 ($M)
11.9 Invega Market Market 2023-2030 ($M) - Regional Industry Research
11.9.1 Invega Market Estimate Forecast Market 2023-2030 ($M)
11.10 Latuda Market Market 2023-2030 ($M) - Regional Industry Research
11.10.1 Latuda Market Estimate Forecast Market 2023-2030 ($M)
11.12 Third Generation Antipsychotic Drug Market 2023-2030 ($M) - Regional Industry Research
11.12.1 Third Generation Antipsychotic Drug Market Market 2023-2030 ($M)
12.APAC Antipsychotic Drug Market:Application Estimate Trend Analysis Market 2023-2030 ($M)
12.1 Schizophrenia Market 2023-2030 ($M) - Regional Industry Research
12.1.1 Schizophrenia Market Estimate Forecast Market 2023-2030 ($M)
12.2 Bipolar Disorder Market 2023-2030 ($M) - Regional Industry Research
12.2.1 Bipolar Disorder Market Estimate Forecast Market 2023-2030 ($M)
12.3 Depression Market 2023-2030 ($M) - Regional Industry Research
12.3.1 Depression Market Estimate Forecast Market 2023-2030 ($M)
12.4 Dementia Market 2023-2030 ($M) - Regional Industry Research
12.4.1 Dementia Market Estimate Forecast Market 2023-2030 ($M)
13.MENA Antipsychotic Drug Market:Drug Class Estimate Trend Analysis Market 2023-2030 ($M)
13.1 First Generation/Standard/Typical Antipsychotic Drug Market 2023-2030 ($M) - Regional Industry Research
13.1.1 First Generation/Standard/Typical Antipsychotic Drug Market Estimate Forecast Market 2023-2030 ($M)
13.2 Haldol Market Market 2023-2030 ($M) - Regional Industry Research
13.2.1 Haldol Market Estimate Forecast Market 2023-2030 ($M)
13.3 Navane Market Market 2023-2030 ($M) - Regional Industry Research
13.3.1 Navane Market Estimate Forecast Market 2023-2030 ($M)
13.5 Second Generation/Atypical Antipsychotic Drug Market 2023-2030 ($M) - Regional Industry Research
13.5.1 Second Generation/Atypical Antipsychotic Drug Market Market Estimate Forecast Market 2023-2030 ($M)
13.6 Zyprexa Market Market 2023-2030 ($M) - Regional Industry Research
13.6.1 Zyprexa Market Estimate Forecast Market 2023-2030 ($M)
13.7 Seroquel Market Market 2023-2030 ($M) - Regional Industry Research
13.7.1 Seroquel Market Estimate Forecast Market 2023-2030 ($M)
13.8 Risperdal Market Market 2023-2030 ($M) - Regional Industry Research
13.8.1 Risperdal Market Estimate Forecast Market 2023-2030 ($M)
13.9 Invega Market Market 2023-2030 ($M) - Regional Industry Research
13.9.1 Invega Market Estimate Forecast Market 2023-2030 ($M)
13.10 Latuda Market Market 2023-2030 ($M) - Regional Industry Research
13.10.1 Latuda Market Estimate Forecast Market 2023-2030 ($M)
13.12 Third Generation Antipsychotic Drug Market 2023-2030 ($M) - Regional Industry Research
13.12.1 Third Generation Antipsychotic Drug Market Market 2023-2030 ($M)
14.MENA Antipsychotic Drug Market:Application Estimate Trend Analysis Market 2023-2030 ($M)
14.1 Schizophrenia Market 2023-2030 ($M) - Regional Industry Research
14.1.1 Schizophrenia Market Estimate Forecast Market 2023-2030 ($M)
14.2 Bipolar Disorder Market 2023-2030 ($M) - Regional Industry Research
14.2.1 Bipolar Disorder Market Estimate Forecast Market 2023-2030 ($M)
14.3 Depression Market 2023-2030 ($M) - Regional Industry Research
14.3.1 Depression Market Estimate Forecast Market 2023-2030 ($M)
14.4 Dementia Market 2023-2030 ($M) - Regional Industry Research
14.4.1 Dementia Market Estimate Forecast Market 2023-2030 ($M)

LIST OF FIGURES

1.US Antipsychotic Drugs Market Revenue, 2023-2030 ($M)
2.Canada Antipsychotic Drugs Market Revenue, 2023-2030 ($M)
3.Mexico Antipsychotic Drugs Market Revenue, 2023-2030 ($M)
4.Brazil Antipsychotic Drugs Market Revenue, 2023-2030 ($M)
5.Argentina Antipsychotic Drugs Market Revenue, 2023-2030 ($M)
6.Peru Antipsychotic Drugs Market Revenue, 2023-2030 ($M)
7.Colombia Antipsychotic Drugs Market Revenue, 2023-2030 ($M)
8.Chile Antipsychotic Drugs Market Revenue, 2023-2030 ($M)
9.Rest of South America Antipsychotic Drugs Market Revenue, 2023-2030 ($M)
10.UK Antipsychotic Drugs Market Revenue, 2023-2030 ($M)
11.Germany Antipsychotic Drugs Market Revenue, 2023-2030 ($M)
12.France Antipsychotic Drugs Market Revenue, 2023-2030 ($M)
13.Italy Antipsychotic Drugs Market Revenue, 2023-2030 ($M)
14.Spain Antipsychotic Drugs Market Revenue, 2023-2030 ($M)
15.Rest of Europe Antipsychotic Drugs Market Revenue, 2023-2030 ($M)
16.China Antipsychotic Drugs Market Revenue, 2023-2030 ($M)
17.India Antipsychotic Drugs Market Revenue, 2023-2030 ($M)
18.Japan Antipsychotic Drugs Market Revenue, 2023-2030 ($M)
19.South Korea Antipsychotic Drugs Market Revenue, 2023-2030 ($M)
20.South Africa Antipsychotic Drugs Market Revenue, 2023-2030 ($M)
21.North America Antipsychotic Drugs By Application
22.South America Antipsychotic Drugs By Application
23.Europe Antipsychotic Drugs By Application
24.APAC Antipsychotic Drugs By Application
25.MENA Antipsychotic Drugs By Application
26.Johnson Johnson, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Geographic Foothold, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Pfizer, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Eli Lilly Co, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Bristol-Myers Squibb Company, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Astrazeneca, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Glaxo Smithkline, Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Allergan, Sales /Revenue, 2015-2018 ($Mn/$Bn)